Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Press

Showing results (31-40 of 273) with videos related to

Pageof 28
Sort By:
Seminars in Oncology|September 11, 1999
The role of immunohistochemistry and fluorescence in situ hybridization for HER2/neu in assessing the prognosis of breast cancerM S Mitchell, M F Press
Laboratory Investigation; a Journal of Technical Methods and Pathology|April 1, 1984
An immunocytochemical method for demonstrating estrogen receptor in human uterus using monoclonal antibodies to human estrophilinM F Press, G L Greene
Journal of Clinical Ultrasound : JCU|January 1, 1988
Assessment of utero-placental blood flow velocity wave forms in a pregnant patient with systemic lupus erythematosusI Meizner, M Katz, F Press
Gynecologic Oncology|June 1, 1985
Endometrial "sarcomas" complicating ovarian thecoma, polycystic ovarian disease and estrogen therapyM F Press, R E Scully
Cancer Medicine|July 23, 2020
Testing considerations for phosphatidylinositol-3-kinase catalytic subunit alpha as an emerging biomarker in advanced breast cancerDeborah L Toppmeyer, Michael F Press
Harefuah|December 15, 1986
[Systemic lupus erythematosus in pregnancy]B Piura, M Katz, F Press
Drugs|September 22, 2007
EGFR, HER2 and VEGF pathways: validated targets for cancer treatmentMichael F Press, Heinz-Josef Lenz
Journal of the National Cancer Institute|April 30, 2009
Alterations in the TOP2A and HER2 genes: association with adjuvant anthracycline sensitivity in human breast cancersDennis J Slamon, Michael F Press
Endocrinology|March 1, 1988
Localization of progesterone receptor with monoclonal antibodies to the human progestin receptorM F Press, G L Greene
The American Journal of Pathology|January 7, 2000
p53 mutations and expression in breast carcinoma in situJ Lukas, N Niu, M F Press
Pageof 28

Showing results (31-40 of 273) with videos related to

Sort By:
Pageof 28
Seminars in Oncology|September 11, 1999
The role of immunohistochemistry and fluorescence in situ hybridization for HER2/neu in assessing the prognosis of breast cancerM S Mitchell, M F Press
Laboratory Investigation; a Journal of Technical Methods and Pathology|April 1, 1984
An immunocytochemical method for demonstrating estrogen receptor in human uterus using monoclonal antibodies to human estrophilinM F Press, G L Greene
Journal of Clinical Ultrasound : JCU|January 1, 1988
Assessment of utero-placental blood flow velocity wave forms in a pregnant patient with systemic lupus erythematosusI Meizner, M Katz, F Press
Gynecologic Oncology|June 1, 1985
Endometrial "sarcomas" complicating ovarian thecoma, polycystic ovarian disease and estrogen therapyM F Press, R E Scully
Cancer Medicine|July 23, 2020
Testing considerations for phosphatidylinositol-3-kinase catalytic subunit alpha as an emerging biomarker in advanced breast cancerDeborah L Toppmeyer, Michael F Press
Harefuah|December 15, 1986
[Systemic lupus erythematosus in pregnancy]B Piura, M Katz, F Press
Drugs|September 22, 2007
EGFR, HER2 and VEGF pathways: validated targets for cancer treatmentMichael F Press, Heinz-Josef Lenz
Journal of the National Cancer Institute|April 30, 2009
Alterations in the TOP2A and HER2 genes: association with adjuvant anthracycline sensitivity in human breast cancersDennis J Slamon, Michael F Press
Endocrinology|March 1, 1988
Localization of progesterone receptor with monoclonal antibodies to the human progestin receptorM F Press, G L Greene
The American Journal of Pathology|January 7, 2000
p53 mutations and expression in breast carcinoma in situJ Lukas, N Niu, M F Press
Pageof 28